Gelonghui, March 19 | Lemei Pharmaceutical (300006.SZ) announced that recently, Chongqing Laimei Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for 20 mg omeprazole magnesium enteric tablets approved and issued by the State Drug Administration.

Omeprazole magnesium enteric tablets are mainly used to treat duodenal ulcers, stomach ulcers and reflux esophagitis; use in combination with antibiotics to treat duodenal ulcers caused by Helicobacter pylori; treat peptic ulcers or gastroduodenal erosion associated with nonsteroidal anti-inflammatory drugs; prevent peptic ulcers, gastroduodenal erosion or indigestion caused by non-steroidal anti-inflammatory drugs; also used for long-term treatment of chronic recurrent peptic ulcers and reflux esophagitis; for cardioesophageal reflux disease Symptomatic treatment of reflux; symptomatic treatment of ulcer-like symptoms and acid-related indigestion; used for Zhuo-Ai Treatment of the syndrome.